|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|
| Net loss | ||
| Cash flows from operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | ||
| Stock-based compensation expense | ||
| Accretion of investment premium, net of amortization of discount | ||
| (Gain) loss on disposal of property and equipment | ||
| Change in fair value of convertible preferred stock warrant liability | ||
| Amortization of debt discount and extinguishment cost | ||
| Non-cash interest expense related to debt costs | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Inventories | ||
| Prepaid expenses and other assets | ||
| Accounts payable | ||
| Accrued and other liabilities | ||
| Net cash provided by (used in) operating activities | ||
| Net cash provided by (used in) operating activities | ||
| Cash flows from investing activities | ||
| Purchases of property and equipment | ||
| Proceeds from sale of PP&E | ||
| Proceeds from sales of short-term investments | ||
| Proceeds from maturities of short-term investments | ||
| Purchases of short-term investments | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Repayments on short and long-term borrowings | ||
| Repayments on line of credit | ||
| Proceeds from line of credit | ||
| Proceeds from exercise of stock options and warrants | ||
| Proceeds from exercise of stock options and preferred stock warrants | ||
| Proceeds from employee stock purchase plan | ||
| Purchases of IP licenses | ||
| Proceeds from initial public offering | ||
| Payment of costs related to initial public offering | ||
| Net increase (decrease) in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Cash and cash equivalents at end of period | ||
| Net cash provided by (used in) financing activities | ||
| Net decrease in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Cash and cash equivalents at end of period | ||
| Supplemental disclosures of cash flow information | ||
| Cash paid for interest | ||
| Cash paid for income taxes | ||
| Non-cash financing and investing transactions | ||
| Reclassification of fair value of warrants to equity from liabilities upon warrant exercise and IPO | ||
| Unpaid costs related to initial public offering | ||
| Property and equipment received and accrued | ||
| Transfer of deferred IPO cost to equity upon IPO |
Loading...
